Josef T Prchal Selected Research

Somatostatinoma

12/2016	Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.
3/2013	Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josef T Prchal Research Topics

Disease

40	Hypoxia (Hypoxemia) 10/2023 - 01/2002
37	Polycythemia (Erythrocytosis) 10/2023 - 12/2002
28	Polycythemia Vera 12/2022 - 06/2004
20	Neoplasms (Cancer) 12/2021 - 02/2003
17	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 05/2005
14	Anemia 01/2023 - 08/2002
11	Essential Thrombocythemia 12/2022 - 03/2010
10	Thrombosis (Thrombus) 10/2023 - 05/2004
8	Glucosephosphate Dehydrogenase Deficiency 01/2021 - 07/2010
7	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019 - 11/2005
6	Inflammation (Inflammations) 01/2023 - 01/2009
6	Hemolysis 01/2020 - 11/2009
5	Hemolytic Anemia 01/2021 - 01/2005
5	Sickle Cell Anemia (Hemoglobin S Disease) 11/2020 - 11/2009
5	Methemoglobinemia 04/2011 - 01/2005
4	Iron Deficiencies 10/2023 - 01/2009
4	Infections 01/2021 - 01/2016
4	primary familial and congenital Polycythemia 01/2016 - 11/2003
4	Pulmonary Hypertension 11/2014 - 06/2006
3	Pain (Aches) 01/2023 - 07/2010
3	Hyperbilirubinemia 12/2021 - 01/2016
3	Jaundice (Icterus) 01/2020 - 01/2014
3	Thrombocytosis (Thrombocythemia) 10/2019 - 04/2003
3	Philadelphia Chromosome 10/2017 - 11/2007
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 03/2010
3	Hypersensitivity (Allergy) 11/2016 - 11/2003
3	Thalassemia 01/2014 - 10/2010
3	Leukemia 12/2012 - 11/2003
3	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 02/2012 - 11/2009
3	hypochromic microcytic Anemia 02/2005 - 04/2004
2	Reticulocytosis 01/2023 - 01/2016
2	Kernicterus 12/2021 - 08/2013
2	Hereditary Pyropoikilocytosis 01/2021 - 12/2013
2	Malaria 11/2020 - 01/2020
2	Neonatal Jaundice 01/2018 - 01/2014
2	Favism 07/2017 - 01/2016
2	Somatostatinoma 12/2016 - 03/2013
2	Paraganglioma (Paragangliomas) 12/2016 - 03/2013
2	Hereditary Elliptocytosis 01/2014 - 12/2013
2	Altitude Sickness (Mountain Sickness) 04/2013 - 01/2005
2	Carcinogenesis 09/2012 - 05/2004
2	Hemangioma (Angioma) 04/2006 - 05/2004
2	Varicose Veins (Varicose Vein) 04/2006 - 05/2004
2	Iron Overload 08/2005 - 04/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2004 - 05/2004
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 05/2004 - 01/2002
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 05/2004 - 12/2002

Drug/Important Bio-Agent (IBA)

33	Erythropoietin FDA Link 10/2023 - 05/2002
18	Hemoglobins (Hemoglobin)IBA 04/2024 - 11/2003
17	IronIBA 10/2023 - 04/2004
16	Oxygen (Dioxygen)IBA 10/2023 - 01/2002
12	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2002
9	Transcription Factors (Transcription Factor)IBA 10/2023 - 05/2004
8	Janus Kinase 2IBA 12/2019 - 11/2005
7	EnzymesIBA 01/2021 - 01/2005
6	HepcidinsIBA 01/2023 - 04/2004
6	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2016 - 11/2003
6	Messenger RNA (mRNA)IBA 12/2013 - 04/2003
5	InterferonsIBA 12/2022 - 10/2015
5	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 10/2015
5	SpectrinIBA 01/2021 - 12/2013
5	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2021 - 10/2012
4	CatalaseIBA 01/2023 - 08/2015
4	ruxolitinibIBA 04/2019 - 10/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2009 - 05/2004
3	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2023 - 01/2005
3	Ferritins (Ferritin)IBA 10/2023 - 02/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 12/2017
3	beta-Globins (beta Globin)IBA 12/2021 - 01/2007
3	GlobinsIBA 01/2021 - 10/2013
3	glucose-6-phosphate dehydrogenase A-IBA 01/2021 - 01/2016
3	BilirubinIBA 01/2020 - 07/2010
3	peginterferon alfa-2a (Pegasys)FDA Link 10/2019 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2007
3	endothelial PAS domain-containing protein 1IBA 12/2016 - 10/2007
3	Imatinib Mesylate (Gleevec)FDA Link 03/2010 - 06/2007
2	Thromboplastin (Tissue Factor)IBA 01/2023 - 01/2022
2	AntioxidantsIBA 01/2023 - 12/2017
2	Interleukin-6 (Interleukin 6)IBA 06/2021 - 11/2009
2	Carbon MonoxideIBA 01/2020 - 01/2016
2	Cytokine Receptors (Cytokine Receptor)IBA 12/2019 - 10/2019
2	C 1311IBA 07/2017 - 04/2012
2	ElementsIBA 11/2016 - 10/2007
2	Sickle HemoglobinIBA 04/2014 - 01/2011
2	Thrombopoietin (c-mpl Ligand)IBA 10/2013 - 10/2005
2	ParaffinIBA 05/2013 - 12/2012
2	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 10/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 06/2012
2	antineoplaston A10 (A 10)IBA 01/2011 - 07/2010
2	CytokinesIBA 01/2011 - 01/2009
2	Amino Acids FDA Link 08/2010 - 12/2002
2	Glutamic Acid (Glutamate)FDA Link 08/2010 - 08/2007
2	A-factor (Streptomyces)IBA 07/2010 - 06/2004
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2007 - 08/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2007 - 11/2005
2	Hypoxia-Inducible Factor 1IBA 09/2004 - 01/2002

Therapy/Procedure

17	Therapeutics 01/2023 - 08/2002
2	Blood Transfusion (Blood Transfusions) 12/2021 - 01/2014
2	Patient Readmission 01/2020 - 01/2016
2	Hematopoietic Stem Cell Transplantation 08/2014 - 05/2005